BioSpace News Archive

Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. (“Fosun Pharma Development”), on the commercialisation of proxalutamide for the treatment of COVID-19 indication in India and 28 African countries (the"Collaboration Regions”).

PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”), is pleased to announce interim positive results from its ongoing preclinical study evaluating the Company’s patented enteric-coated formulation of Cepharanthine (“PD-001") in a broad panel of human cancers.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today the appointment of Anna Diaz Triola as Chief Commercial Officer, effective July 19th 2021.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Aundrietta Duncan, Ph.D., Director, Non-Clinical Development at Salarius Pharmaceuticals, has been invited to present during the Epigenetic Therapeutic Targets Summit.

BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced changes to its board of directors.

NanoDx, Inc., a privately held medical device company developing breakthrough, point-of-care diagnostic solutions, today announced a licensing agreement with IBM Research for use of its metal-oxide semi-conductive (“CMOS”) compatible nanoscale sensors to enhance and expand accurate, rapid testing for several indications, including COVID-19,

Welltower Inc. (NYSE: WELL) today announced that it will release second quarter 2021 financial results after the close of trading on the New York Stock Exchange on Thursday, July 29, 2021. The Company will host a conference call and webcast on Friday, July 30 , 2021 at 9:00 a.m. Eastern Time to discuss these results.

Evvy, a female-founded startup that aims to build a new understanding of the female body, launches today

Synaptogenix, Inc. today announced that its abstract has been accepted at the Alzheimer’s Association International Conference (“AAIC”), which will be held online and in-person July 26-30, 2021 .

Curia announced it has entered into a definitive agreement to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with operations in California, Massachusetts, and Texas.